HomeMRVL • CVE
add
Marvel Biosciences Corp
Previous close
$0.18
Day range
$0.18 - $0.18
Year range
$0.060 - $0.19
Market cap
7.19M CAD
Avg Volume
81.63K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Apr 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 228.70K | -65.05% |
Net income | -307.31K | 57.10% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Apr 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 217.69K | -78.28% |
Total assets | 347.27K | -71.54% |
Total liabilities | 3.10M | 77.51% |
Total equity | -2.76M | — |
Shares outstanding | 39.79M | — |
Price to book | -2.57 | — |
Return on assets | -108.04% | — |
Return on capital | 51.70% | — |
Cash Flow
Net change in cash
| (CAD) | Apr 2024info | Y/Y change |
|---|---|---|
Net income | -307.31K | 57.10% |
Cash from operations | -359.98K | -21.56% |
Cash from investing | — | — |
Cash from financing | 0.00 | -100.00% |
Net change in cash | -359.98K | -151.14% |
Free cash flow | -217.51K | -1,808.33% |
About
Founded
2021
Headquarters
Website
